Insider · CIK 0001236030
Geert R Kersten
Files at CVM (CEL SCI CORP). First filing Jul 28, 2025, latest May 18, 2026.
Geert R Kersten files SEC Form 4 as CEO and director at CVM (CEL SCI CORP). Since Jul 28, 2025, Geert R Kersten has reported 5 open-market buys worth $929k and 0 open-market sells worth $0, the latest filed on May 18, 2026.
A track record needs three past buys with six months of prices behind them; Geert R Kersten has 0, so none is measured yet.
The newest scored trade: bought $360k of CVM on May 14, 2026, filed May 18, 2026, scored 73 (notable). In the last 12 months: 4 buys worth $729k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CVM: CEL SCI CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 73Notable | CVMbuy CEL SCI CORP | $360k 300,000 shares | +2598% | +9% from low-90% from high | |
| 63Notable | CVMbuy CEL SCI CORP | $119k 100,000 shares | +82% | +1% from low-91% from high | |
| 56Moderate | CVMbuy CEL SCI CORP | $200k 38,023 shares | +46% | +205% from low-58% from high | |
| 35Weak | CVMbuy CEL SCI CORP | $50k 8,389 shares | +11% | - | |
| 55Moderate | CEL SCI CORP | $200k 29,197 shares | +67% | - |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | CVM CEL SCI CORP | AGrant or award Common Stock | +2,621 | $2.06 | $5,399 | 318,763 | 12 d ago |
| May 14, 2026 | CVM CEL SCI CORP | POpen-market purchase Common Stockindirect: Trustee | +300,000 | $1.20 | $360k | 311,547 | May 18, 2026 |
| May 13, 2026 | CVM CEL SCI CORP | POpen-market purchase Common Stock | +100,000 | $1.19 | $119k | 222,497 | May 14, 2026 |
| Mar 31, 2026 | CVM CEL SCI CORP | AGrant or award Common Stock | +1,682 | $3.21 | $5,399 | 122,497 | Apr 1, 2026 |
| Jan 22, 2026 | CVM CEL SCI CORP | POpen-market purchase Common Stock | +38,023 | $5.26 | $200k | 120,815 | Jan 26, 2026 |
| Dec 31, 2025 | CVM CEL SCI CORP | AGrant or award Common Stock | +998 | $5.26 | $5,249 | 82,792 | Jan 5, 2026 |
| Dec 4, 2025 | CVM CEL SCI CORP | POpen-market purchase Common Stock | +8,389 | $5.96 | $50k | 81,794 | Dec 5, 2025 |
| Sep 30, 2025 | CVM CEL SCI CORP | AGrant or award Common Stock | +570 | $9.20 | $5,244 | 73,405 | Oct 2, 2025 |
| Jul 28, 2025 | CVM CEL SCI CORP | AGrant or award Optionsderivative | +25,000 | $0.01 | $250 | 175,157 | Jul 29, 2025 |
| Jul 25, 2025 | CVM CEL SCI CORP | POpen-market purchase Common Stock | +29,197 | $6.85 | $200k | 72,835 | Jul 28, 2025 |
| Jun 30, 2025 | CVM CEL SCI CORP | AGrant or award Common Stock | +2,292 | $2.29 | $5,249 | 43,638 | Jul 1, 2025 |
| Mar 31, 2025 | CVM CEL SCI CORP | AGrant or award Common Stock | +22,786 | $0.23 | $5,250 | 1,240,378 | Apr 1, 2025 |
| Dec 31, 2024 | CVM CEL SCI CORP | AGrant or award Common Stock | +12,940 | $0.40 | $5,176 | 1,217,592 | Jan 2, 2025 |
Questions about Geert R Kersten
Answered from the filings on this page, as of the latest one.
Is Geert R Kersten buying or selling?
In the last 12 months Geert R Kersten reported 4 open-market buys worth $729k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $360k of CVM on May 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Geert R Kersten's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geert R Kersten has 0.
Where does Geert R Kersten file Form 4?
Geert R Kersten has filed Form 4 at CVM (CEL SCI CORP) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.